Polaris Partners
@PolarisVC
Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators. Learn more at http://polarispartners.com.
Vous pourriez aimer
Congrats to the @dewpoint_tx team on the strategic partnership with @Evotec. Read more here: globenewswire.com/news-release/2…
Congrats to @BeMeHQ on partnering with major health plans to support teen mental health. Read more here: medcitynews.com/2023/11/teen-m…
Congrats to the Engine Biosciences team on today's funding round to advance the development of precision oncology medicines. Read more here: finance.yahoo.com/news/engine-bi…
Congrats to the @VolastraTx team on this milestone
We've dosed the first patient in our #clinicaltrial of VLS-1488, our internally discovered #KIF18A inhibiting drug designed to treat patients with advanced cancers characterized by high levels of chromosomal instability: bit.ly/3QkleIb.
We are pleased to see Triveni Bio up and running! Formed with important contributions from Polaris Partners repeat entrepreneurs Tillman Gerngross and Leonard Zon at Amagma, now Triveni. Read more here: biopharmadive.com/news/triveni-b…
Congrats to the @Dyno_Tx team on today's launch!
Today at #ESGCT2023 we were excited to announce the launch of our Dyno eCap™ 1 capsid, an eye targeting AAV 👁️🧬 with dramatically improved transduction to clinically-relevant cell types across the retina. Learn more at: products.dynotx.com/ecap1/
Congrats to the @ankyratx team on receiving FDA IND and Health Canada CTA approval. Read more about it here: businesswire.com/news/home/2023…
businesswire.com
Ankyra Therapeutics Receives FDA IND and Health Canada CTA Approval to Advance First-In-Class...
Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced approval of its investigatio...
Exciting news for @Om1Inc!
We're excited to announce that PhenOM is a finalist for the @FierceHealth Innovation Award in the Data Analytics/Business Intelligence category! 📍View all finalists: hubs.ly/Q025Svbj0 #AI #ArtificialIntelligence #DigitalHealth #DataAnalytics
Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, the Polaris Innovation Fund, and Evotec SE are announcing the launch of 65LAB to advance drug discovery and the creation of new therapeutics companies in Singapore. Read more about it here: prnewswire.com/news-releases/…
Kudos to the @ankyratx team!
Exciting news today as we announce our clinical trial collaboration and supply agreement with @Merck to assess ANK-101 in combination with Keytruda® (pembrolizumab) in patients with solid tumors. Read more: ankyratx.com/press-release/…
Congrats to the @Om1Inc team
We're excited to announce the launch of two new clinical datasets, #ChronicRhinosinusitis and #Asthma, with each following approximately 500,000 patients in the U.S. 📍Read the full release: hubs.ly/Q023-t_-0 #CRS #SDoH #ENT #Respiratory #Otolaryngology
Congrats @polarisvc partner @CohereHealth team for delivering real impact & building great culture Here are the top startups to work for in 2023, according to LinkedIn today.com/video/here-are… via @TODAYshow
Kudos to the Seismic Therapeutics team on being named to the @endpts Endpoints 11 list of most promising biotech startups! businesswire.com/news/home/2023…
Congrats to the Seraxis team on the funding and completion of preclinical studies. Read more here: biospace.com/article/releas…
Congrats to the @BaxterPlanning team!
Baxter Planning's predictive Service Supply Chain platform chosen by Roche Diagnostics Corporation for Service Supply Chain. Read the full press release here: prn.to/46idPiY #ServicePartsManagement #RocheDiagnostics #BaxterPlanning
Kudos to the @dewpoint_tx team on the partnership with @ChemifyX
Today we announced our revolutionary partnership with @ChemifyX to apply groundbreaking AI to radically accelerate the discovery of molecules targeting cancer and neurodegeneration. "This is a new frontier in drug discovery..." Read more here: dewpointx.com/dewpoint-thera…
Kudos to the OM1 team on the launch of Parkinson's datasets for neuroscience: hitconsultant.net/2023/09/07/om1…
Congrats to the @KSQ_TX team on the collaboration with CTMC. An important step in the treatment of solid tumors businesswire.com/news/home/2023…
Congrats to the @falkonry team on the acquisition prnewswire.com/news-releases/…
prnewswire.com
IFS to acquire Falkonry AI
/PRNewswire/ -- IFS, the global cloud enterprise software company, today announced it has signed a definitive agreement to acquire Falkonry, Inc. a...
Big news for the @byheartbaby team!
Hello families everywhere: ByHeart is BACK! We truly cannot begin to explain how excited we are to announce that we are exclusively launching with one of the nation’s biggest retailers—Target! Find ByHeart in your local Target store. byheart.com/pages/store-lo…
United States Tendances
- 1. Arsenal 202K posts
- 2. Martinelli 16.6K posts
- 3. White House 476K posts
- 4. Atlas 57.7K posts
- 5. Atletico 87.5K posts
- 6. Rashford 59.5K posts
- 7. Crosby 7,518 posts
- 8. Lakers 37.2K posts
- 9. Woody Johnson 2,411 posts
- 10. Gyokeres 22.6K posts
- 11. Simeone 14.9K posts
- 12. #ARSATM 4,675 posts
- 13. NASA 68.8K posts
- 14. Lewis Skelly 10.2K posts
- 15. #COYG 3,072 posts
- 16. John Brennan 24.2K posts
- 17. #pilotstwtselfieday 1,687 posts
- 18. $BYND 151K posts
- 19. Platner 9,273 posts
- 20. Fermin 85.4K posts
Vous pourriez aimer
-
Flagship Pioneering
@FlagshipPioneer -
Atlas Venture
@atlasventure -
Bruce Booth
@LifeSciVC -
Timmerman Report
@timmermanreport -
Endpoints News
@endpts -
Noubar Afeyan
@NoubarAfeyan -
Jeb Keiper
@JebKeiper -
Luke Timmerman
@ldtimmerman -
Vida Ventures
@Vida_Ventures -
General Catalyst
@generalcatalyst -
Arrakis Therapeutics
@ArrakisTx -
The New England Venture Capital Association
@NewEnglandVC -
Menlo Ventures
@MenloVentures -
Spark Capital
@sparkcapital -
John Maraganore 🇺🇸🇬🇷🇺🇦
@JMaraganore
Something went wrong.
Something went wrong.